Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer-MedSci.cn

Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Ruiz-Borrego, M; Chan, A; Marx, G; Brufsky, A; Chien, AJ; Thirlwell, M; Trudeau, M; Bose, R; Garcia-Saenz, JA; Egle, D; Hunt, D; Khambholja, U; McCulloch, L; Shah, N; Tripathy, D; Barcenas, CH

CANCER RESEARCH, 2021; 81 (4):

科室
- - 订阅+
  - 更多科室
工具
服务